The Global Asthma & COPD Market Report drugs represents an area. For more mail: vikas@konceptanalytics.com

1. Global Asthma Market Report
-----------------------------------------
2015
View Report Details

2. Executive Summary
 Asthma is a common chronic disease linking the airway in the lungs that affects the people of all age groups. The airways or
bronchial tubes, allow air to come in and out of the lungs. The airway of asthmatic patients is generally inflamed and becomes
swollen over time. This makes it difficult for air to move in and out of the lungs, causing symptoms such as coughing, wheezing,
shortness of breath and/ or chest tightness.
 The prevalence of asthma is expected to increase significantly in the coming years. The market for asthma drugs is driven by
various factors including increasing global spending on medicines, increasing tobacco and cigarette consumption, rising
prevalence of non-communicable diseases, more use of biologics, and increasing healthcare expenditure worldwide. The major
upcoming trends in the asthma market include introduction of new severe asthma and Chronic Obstructive Pulmonary Disease
(COPD) drugs, and introduction of new mechanisms that will help drive the market. However, there are certain challenges
hindering the growth of the market. Such challenges include increased pricing pressures, patent expiries and introduction of
generic drugs in the market.
 The market for asthma and COPD drugs represents an area of potential opportunity in both developed and developing countries.
Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative asthma
and COPD drugs and treatments. Further, the companies are combining businesses and spending comprehensively on research
and development to develop effective treatment methods for asthma.
 The present report provides a comprehensive analysis of the global asthma & COPD market with focus on regions like the U.S.
and European Union. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers
and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in
terms of research and development of novel therapeutic molecules. The leading players operating in the industry include
AstraZeneca, Merck and Co., Roche, Sanofi and Novartis which are also profiled in this report.
View Report Details

3. The Global Respiratory Market has high growth potential due to expected increase in the treatment rate in
the coming years…
 For the year 2014, the global respiratory market is
estimated to have reached US$.. billion and is further
estimated to increase to US$.. billion by 2018, increasing
from US$... billion in 2012, registering a CAGR of ..% for
the period 2012-2018.
 The U.S. is estimated to have held the maximum share in
the global respiratory market with ..%, followed by the top
EU5 region with ..% share. Japan with ..% share in the
respiratory market was followed by Latin America with ..%
share.
 The global respiratory drugs market reached US$.. billion
in 2014 compared to US$.. billion in 2013, a decline of ..%.
The market for respiratory drugs is further estimated to fall
by ..% in 2015 with revenues reaching US$... billion
Global Respiratory Market by Regions (2014E)
Global Respiratory Market (2012-2018E)
Global Respiratory Therapeutics Market (2010-2015E)
2012 2014E 2018E
US$Billion
The U.S. EU5 Japan Latin America Rest of the World
-10%
-5%
0%
5%
10%
15%
20%
2010 2011 2012 2013 2014 2015E
US$Billion
Drug Sales Y-O-Y Growth

4. Both prevalence and mortality for respiratory diseases is increasing, which is likely to bring significant
opportunity for the industry…
 The global asthma market stood at US$.. billion in 2012, and is
estimated to have reached US$... billion by the end of 2014. The
global asthma market is further estimated to reach US$.. billion by
2022. The market is expected to grow modestly at a CAGR of ..%
for the period spanning 2012-2017.
 In 2014, the global COPD market is estimated to have reached
US$.. billion increasing from US$.. billion in 2012. The market is
further estimated to reach US$... billion and US$.. billion by the end
of 2017 and 2022 respectively.
 By 2017, the U.S. is expected to hold the maximum share in the
global asthma/COPD market with ..% share, followed by the five
major countries of the European Union which are expected to hold
…% share. The BRIC nations will be holding ..% share in the global
asthma/COPD market followed by Japan with …%.
Global COPD Market by Value (2012-2022E)
Global Asthma Market by Value (2012-2022E)
Global Asthma/COPD Market by Region (2017E)
2012 2014E 2017E 2022E
US$Billion
2012 2014E 2017E 2022E
US$Billion
The U.S. EU5 BRIC Japan Others

5. A set of new treatment opportunities are now on the verge of reaching the market, for sever asthma
treatment, thus driving the overall asthma market..
 In 2014, the global asthma/COPD therapeutics market reached
US$... billion registering an annual decline of ..% from the
previous year’s revenue of US$.. billion. The market is estimated
to decline further by ..% and reach US$...billion by the end of
2015.
 The global severe asthma market is estimated to have reached
US$.. Million in 2014 increasing from US$.. million in the previous
fiscal. The market for severe asthma is expected to rise
significantly over the years and reach US$...billion by the end of
2022.
 The severe asthma biologics market is estimated to have three
different inhibitors category by the end of year 2022. Of the three
inhibitors, IL-5 Inhibitors is estimated to capture ..% of the total
market followed by IL-13 Inhibitors/IL-4 Inhibitors with …% share.
Global Severe Asthma Biologics Market Forecast (2013-2022E)
Global Asthma/COPD Therapeutics Market (2010-2015E)
Global Severe Asthma Biologics Market by Drugs (2022E)
-10%
-5%
0%
5%
10%
15%
20%
2010 2011 2012 2013 2014 2015E
US$Billion
Drug Sales Y-O-Y Growth
2013 2014E 2015E 2016E 2017E 2018E 2019E 2020E 2021E 2022E
US$Million
IL-5 Inhibitors IL-13/1L-4 Inhibitors IgE Inhibitors

6. Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Asthma Market” . To know
more about this report or for any customized research requirement, please contact the following:
View Report Details